-
1
-
-
84867437406
-
Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses
-
Bagarazzi, ML, Yan, J, Morrow, MP, Shen, X, Parker, RL, Lee, JC et al. (2012). Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses. Sci Transl Med 4: 155ra138.
-
(2012)
Sci Transl Med
, vol.4
-
-
Bagarazzi, M.L.1
Yan, J.2
Morrow, M.P.3
Shen, X.4
Parker, R.L.5
Lee, J.C.6
-
2
-
-
84870869040
-
Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection
-
Petsch, B, Schnee, M, Vogel, AB, Lange, E, Hoffmann, B, Voss, D et al. (2012). Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection. Nat Biotechnol 30: 1210-1216.
-
(2012)
Nat Biotechnol
, vol.30
, pp. 1210-1216
-
-
Petsch, B.1
Schnee, M.2
Vogel, A.B.3
Lange, E.4
Hoffmann, B.5
Voss, D.6
-
3
-
-
84865994357
-
Nonviral delivery of self-amplifying RNA vaccines
-
Geall, AJ, Verma, A, Otten, GR, Shaw, CA, Hekele, A, Banerjee, K et al. (2012). Nonviral delivery of self-amplifying RNA vaccines. Proc Natl Acad Sci USA 109: 14604-14609.
-
(2012)
Proc Natl Acad Sci USA
, vol.109
, pp. 14604-14609
-
-
Geall, A.J.1
Verma, A.2
Otten, G.R.3
Shaw, C.A.4
Hekele, A.5
Banerjee, K.6
-
4
-
-
84871926389
-
Type i IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines
-
Pollard, C, Rejman, J, De Haes, W, Verrier, B, Van Gulck, E, Naessens, T et al. (2013) Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines. Mol Ther 21: 251-259.
-
(2013)
Mol Ther
, vol.21
, pp. 251-259
-
-
Pollard, C.1
Rejman, J.2
De Haes, W.3
Verrier, B.4
Van Gulck, E.5
Naessens, T.6
-
5
-
-
52449104809
-
DNA vaccines: Ready for prime time?
-
Kutzler, MA and Weiner, DB (2008). DNA vaccines: ready for prime time? Nat Rev Genet 9: 776-788.
-
(2008)
Nat Rev Genet
, vol.9
, pp. 776-788
-
-
Kutzler, M.A.1
Weiner, D.B.2
-
6
-
-
0029887746
-
Polynucleotide-mediated immunization therapy of cancer
-
Conry, RM, LoBuglio, AF and Curiel, DT (1996). Polynucleotide-mediated immunization therapy of cancer. Semin Oncol 23: 135-147.
-
(1996)
Semin Oncol
, vol.23
, pp. 135-147
-
-
Conry, R.M.1
Lobuglio, A.F.2
Curiel, D.T.3
-
7
-
-
23244456102
-
DNA vaccines: Progress and challenges
-
Donnelly, JJ, Wahren, B and Liu, MA (2005). DNA vaccines: progress and challenges. J Immunol 175: 633-639.
-
(2005)
J Immunol
, vol.175
, pp. 633-639
-
-
Donnelly, J.J.1
Wahren, B.2
Liu, M.A.3
-
8
-
-
79957781340
-
Electroporation delivery of DNA vaccines: Prospects for success
-
Sardesai, NY and Weiner, DB (2011). Electroporation delivery of DNA vaccines: prospects for success. Curr Opin Immunol 23: 421-429.
-
(2011)
Curr Opin Immunol
, vol.23
, pp. 421-429
-
-
Sardesai, N.Y.1
Weiner, D.B.2
-
9
-
-
2942559009
-
Cancer immunotherapy with mRNA-transfected dendritic cells
-
Gilboa, E and Vieweg, J (2004). Cancer immunotherapy with mRNA-transfected dendritic cells. Immunol Rev 199: 251-263.
-
(2004)
Immunol Rev
, vol.199
, pp. 251-263
-
-
Gilboa, E.1
Vieweg, J.2
-
10
-
-
77954544704
-
RNA vaccines in cancer treatment
-
Bringmann, A, Andrea, SA, Held, E, Heine, A and Brossart, P (2010). RNA vaccines in cancer treatment. J Biomed Biotechnol 2010: 623687.
-
(2010)
J Biomed Biotechnol
, vol.2010
, pp. 623687
-
-
Bringmann, A.1
Andrea, S.A.2
Held, E.3
Heine, A.4
Brossart, P.5
-
11
-
-
0032965983
-
Non-viral amplification systems for gene transfer: Vectors based on alphaviruses
-
Smerdou, C and Liljestrom, P (1999). Non-viral amplification systems for gene transfer: vectors based on alphaviruses. Curr Opin Mol Ther 1: 244-251.
-
(1999)
Curr Opin Mol Ther
, vol.1
, pp. 244-251
-
-
Smerdou, C.1
Liljestrom, P.2
-
12
-
-
84862855875
-
Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination
-
Desmet, CJ and Ishii, KJ (2012). Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination. Nat Rev Immunol 12: 479-491.
-
(2012)
Nat Rev Immunol
, vol.12
, pp. 479-491
-
-
Desmet, C.J.1
Ishii, K.J.2
-
13
-
-
54949112814
-
Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability
-
Karikó, K, Muramatsu, H, Welsh, FA, Ludwig, J, Kato, H, Akira, S and Weissman, D (2008). Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol Ther 16:1833-1840.
-
(2008)
Mol Ther
, vol.16
, pp. 1833-1840
-
-
Karikó, K.1
Muramatsu, H.2
Welsh, F.A.3
Ludwig, J.4
Kato, H.5
Akira, S.6
Weissman, D.7
|